Ridouani, Fourat
Doustaly, Raphael
Yarmohammadi, Hooman
Solomon, Stephen B.
Gonzalez-Aguirre, Adrian J. http://orcid.org/0000-0002-7604-5788
Funding for this research was provided by:
National Cancer Institute (P30 CA008748)
Article History
Received: 11 August 2020
Accepted: 5 January 2021
First Online: 20 January 2021
Compliance with Ethical Standards
:
: Homan Yarmohammadi has research funding from RSNA Scholar Grant, SIR Ernest Ring Academic Development, Guerbet Group and Thompson Foundation. He is an advisory board member of Management of Ascites Advisory Board of BD Medical and Management of HCC Advisory Board of Genentech. Stephen Solomon has consulting fees from BTG, Johnson & Johnson, Varian, XACT Robotics, Endoways and Aperture. He holds grants from GE Healthcare, AngioDynamics, Elestra, Johnson & Johnson. He is a shareholder of Aperture and Johnson & Johnson. All the other authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this retrospective study, formal consent is not required, and was waived by institutional IRB.
: This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748
: For this type of study, consent for publication is not required.